close
Tarkan Demirbas
Tarkan Demirbas

GCC survey reveals need for innovation to address harm reduction strategies

DUBAI: A new survey conducted across the Kingdom of Saudi Arabia (KSA), the Kingdom of Bahrain, the United Arab Emirates (UAE), and Kuwait has revealed how industries, particularly the tobacco industry, must take bigger steps towards product innovation to reduce harm. The survey, conducted independently by leading Dubai-based market research company 4SiGHT, was commissioned by Philip Morris Management Services (Middle East) Limited. (PMMS) to understand how the general public viewed the subject of harm reduction and their perspective on companies that are undertaking similar initiatives.

Drawing on the opinion of more than 2,500 respondents across the four GCC countries, the survey revealed that a majority of Kuwait participants (62 percent) strongly believe product innovation is key to harm reduction. Similarly, 45 percent of participants equally in the UAE and KSA also believe the same. Meanwhile, among participants in Bahrain and Kuwait, an impressive 86 percent and 89 percent respectively identified tobacco as one of the key industries that should undergo transformation to address harm. Following tobacco, a majority of respondents across all four markets also pointed out fast food, pharma, automotive and chemical industries as key industries that must innovate and implement transformational practices to create less-harmful alternatives.

To initially measure the foundational understanding of harm reduction across all markets, the survey explored the general public’s comprehension, familiarity with harm reduction practices, and whether they were implemented on a habitual or awareness-led basis. The majority of the population across all markets claimed to be familiar with the concept, especially Kuwait participants (47 percent) fairing higher than 13 percent of participants in Bahrain, 15 percent in the UAE, and 17 percent in Saudi Arabia. When asked about harm reduction in practice, respondents cited using seatbelts, hybrid and electric vehicles, bike helmets and vaccinations as more salient harm reduction practices.

The survey also revealed that in all four markets, harm reduction practices were more habitual than awareness driven. While many were aware that their practices would prevent harm, the majority also unknowingly engaged in these practices without realizing they fell under the definition of “harm reduction” concepts. Common harm reduction practices, both known and unknown, across the GCC included using sun protection, refrigerating food, vaccinations, and wearing seat belts.

Based on the survey findings that highlighted how industries, predominantly tobacco, must embrace harm reduction practices, the general overall population believed burnt chemicals, nicotine, tar, and carbon monoxide to be the key elements that need to be addressed by the tobacco industry. A significant67 percent of Kuwait participants were convinced that harm reduction is extremely important for adult smokers, while 51 percent of UAE respondents strongly feel that adult cigarette smokers should switch to less-harmful alternatives.

Tarkan Demirbas, Area Vice-President Middle East, Philip Morris Management Services (Middle East) Limited, commented: “These survey findings underscore the urgent call to action for leading organizations especially those operating in highly regulated sectors like tobacco to innovate and develop better alternatives that replace products bringing harm to public health. As consumers become increasingly conscious of what they consume, businesses must practice accountability by embracing product innovation and consequently, company-wide transformation.

At Philip Morris International (PMI), we’ve taken up this approach with unwavering determination, placing consumer well-being at the very heart of our operations. Our commitment is about creating a far-reaching, positive impact on society as a whole. This commitment centers on harm reduction as the cornerstone of our journey towards a smoke-free future.”

The results of the 4SiGHT survey align with PMI’s strategic transformation journey toward creating a smoke-free future. Awareness of heated tobacco products are relatively high across all four markets, especially in Kuwait, leading with 48 percent. While not risk-free, when scientifically developed and made to appropriate quality and safety standards, heated tobacco products can be better alternatives to cigarettes. PMI is already bringing this solution in the form of its heated tobacco product, and other smoke free products available in 82 markets as of September, 20231.

Being informed and educated continues to be critical when discussing harm reduction and smoking. 61 percent of the population in Kuwait firmly believe adult smokers should be given accurate, scientifically backed information to make informed choices on new-age options, followed by 43 percent in Saudi Arabia, 37 percent in the UAE, and 36 percent in Bahrain.

PMI’s transition to a smoke-free future is based on the premise of informing adult smokers on how harm reduction can benefit public health by minimizing morbidity from smoking-related diseases and extending longevity. The best choice for any smoker is to completely quit tobacco and nicotine products. However, many don’t. For those adults who would otherwise continue to smoke, there are better alternatives. PMI is transforming for good to deliver smoke-free products to adults who would otherwise continue to smoke cigarettes.

4SiGHT survey methodology

4SiGHT conducted this online survey on behalf of PMI between in August 2023. It comprised of online CAWI (Computer-assisted web interviewing) interviews with general adult population and a structured questionnaire. The survey was fielded among 2,821legal-aged adult respondents, drawn from the general population, and aged 18 or older in Bahrain, Saudi Arabia, the United Arab Emirates and Kuwait.

Smoke-free future

Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested more than $10.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes.

This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The US Food and Drug Administration has authorized versions of PMI’s IQOS Platform 1 devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products.

As of September 30, 2023, PMI’s smoke-free products were available for sale in 82 markets, and PMI estimates that approximately 19.7 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products accounted for approximately 36.2 percent of PMI’s total third-quarter 2023 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its VecturaFertin Pharma business, aims to enhance life through the delivery of seamless health experiences.

By Nermeen Al-Houti The sounds of the Saudi musical group “Choralla” illuminated the Kuwaiti sky last Thursday, as part of the “Shetaa Al-Kuwait 2024” festival held at the Sheikh Jaber Al-Ahmad Cultural Center. Known for their mastery in com...
For years, numerous stakeholders have engaged in extensive dialogues with health service providers, all with one goal in mind: to ensure that the patient remains the focal point of healthcare. Yet, despite these ongoing efforts, patients continue to...
MORE STORIES